Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionDNA translocase activity

ATRX FBH1 RAD54L

2.32e-0651243GO:0015616
GeneOntologyMolecularFunctionATP-dependent activity

MYH6 ATP8B4 ATRX KIF26A KIF26B DHX37 RFC1 SMC2 ATP8B2 KIF20B DNAH14 FBH1 SMC3 SLC27A5 RAD54L

6.33e-0661412415GO:0140657
GeneOntologyMolecularFunctionvasopressin receptor activity

AVPR1B NPSR1 OXTR

8.03e-0671243GO:0005000
GeneOntologyMolecularFunctionsteroid hydroxylase activity

CYP2A6 CYP2A7 CYP3A4 CYP3A5

5.69e-05341244GO:0008395
GeneOntologyMolecularFunctionaromatase activity

CYP2A6 CYP2A7 CYP3A4 CYP3A5

6.39e-05351244GO:0070330
GeneOntologyMolecularFunctionmicrotubule motor activity

KIF26A KIF26B KIF20B DNAH14 SMC3

7.46e-05701245GO:0003777
GeneOntologyMolecularFunctioncytoskeletal motor activity

MYH6 KIF26A KIF26B KIF20B DNAH14 SMC3

9.49e-051181246GO:0003774
GeneOntologyMolecularFunctionATP hydrolysis activity

ATP8B4 ATRX KIF26A DHX37 RFC1 SMC2 ATP8B2 KIF20B FBH1 SMC3 RAD54L

9.71e-0544112411GO:0016887
GeneOntologyMolecularFunctioncoumarin 7-hydroxylase activity

CYP2A6 CYP2A7

1.14e-0431242GO:0008389
GeneOntologyMolecularFunctiontestosterone 16-alpha-hydroxylase activity

CYP3A4 CYP3A5

2.28e-0441242GO:0008390
GeneOntologyMolecularFunctionoxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen

CYP2A6 CYP2A7 CYP3A4 CYP3A5

2.42e-04491244GO:0016712
GeneOntologyMolecularFunctiontestosterone 6-beta-hydroxylase activity

CYP3A4 CYP3A5

3.78e-0451242GO:0050649
GeneOntologyMolecularFunctionvitamin D 23-hydroxylase activity

CYP3A4 CYP3A5

3.78e-0451242GO:0062179
GeneOntologyMolecularFunction1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity

CYP3A4 CYP3A5

3.78e-0451242GO:0062181
GeneOntologyMolecularFunctionvitamin D3 25-hydroxylase activity

CYP3A4 CYP3A5

5.65e-0461242GO:0030343
GeneOntologyMolecularFunctionvitamin D 24-hydroxylase activity

CYP3A4 CYP3A5

5.65e-0461242GO:0070576
GeneOntologyMolecularFunctionvitamin D 25-hydroxylase activity

CYP3A4 CYP3A5

7.87e-0471242GO:0070643
GeneOntologyMolecularFunctionoxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor

CYP3A4 CYP3A5

1.05e-0381242GO:0033695
GeneOntologyMolecularFunctioncaffeine oxidase activity

CYP3A4 CYP3A5

1.05e-0381242GO:0034875
GeneOntologyMolecularFunctionestrogen 2-hydroxylase activity

CYP3A4 CYP3A5

1.05e-0381242GO:0101021
GeneOntologyMolecularFunctioncatalytic activity, acting on DNA

ATRX POLA1 RFC1 TERF1 FBH1 RAD54L DNTT

1.26e-032621247GO:0140097
GeneOntologyMolecularFunctionsingle-stranded DNA binding

POLA1 SMC2 TERF1 FBH1 RAD54L

1.50e-031341245GO:0003697
GeneOntologyMolecularFunctionoxygen binding

CYP2A7 CYP3A4 CYP3A5

1.56e-03371243GO:0019825
GeneOntologyMolecularFunctionDNA polymerase activity

POLA1 TERF1 DNTT

1.68e-03381243GO:0034061
GeneOntologyMolecularFunctionestrogen 16-alpha-hydroxylase activity

CYP3A4 CYP3A5

2.03e-03111242GO:0101020
GeneOntologyMolecularFunctiontRNA (guanine) methyltransferase activity

TRMT11 TARBP1

2.42e-03121242GO:0016423
GeneOntologyMolecularFunctiondemethylase activity

CYP3A4 CYP3A5 KDM4A

2.57e-03441243GO:0032451
DomainVasoprsn_rcpt

AVPR1B NPSR1 OXTR

2.97e-0651263IPR001817
DomainCyt_P450_E_grp-I_CYP2A-like

CYP2A6 CYP2A7

2.69e-0441262IPR008067
DomainBAGE

BAGE2 BAGE3

4.46e-0451262IPR012530
DomainBAGE

BAGE2 BAGE3

4.46e-0451262PF08180
DomainSMC

SMC2 SMC3

4.46e-0451262IPR024704
DomainCyt_P450_E_grp-II

CYP3A4 CYP3A5

4.46e-0451262IPR002402
DomainCyt_P450_CS

CYP2A6 CYP2A7 CYP3A4 CYP3A5

4.48e-04531264IPR017972
DomainSpectrin

DRP2 SPTAN1 SYNE2

4.81e-04231263PF00435
DomainCYTOCHROME_P450

CYP2A6 CYP2A7 CYP3A4 CYP3A5

5.92e-04571264PS00086
DomainP-loop_NTPase

ADCY10 MYH6 ATRX KIF26A KIF26B DHX37 RFC1 SMC2 KIF20B DNAH14 RND3 FBH1 SMC3 IQCB1 RAD54L

5.95e-0484812615IPR027417
Domain-

CYP2A6 CYP2A7 CYP3A4 CYP3A5

6.32e-045812641.10.630.10
Domainp450

CYP2A6 CYP2A7 CYP3A4 CYP3A5

6.32e-04581264PF00067
DomainCyt_P450_E_CYP3A

CYP3A4 CYP3A5

6.65e-0461262IPR008072
DomainSMC_hinge

SMC2 SMC3

6.65e-0461262SM00968
DomainSMC_hinge

SMC2 SMC3

6.65e-0461262PF06470
DomainSMC_hinge

SMC2 SMC3

6.65e-0461262IPR010935
DomainCyt_P450

CYP2A6 CYP2A7 CYP3A4 CYP3A5

7.19e-04601264IPR001128
DomainSpectrin_repeat

DRP2 SPTAN1 SYNE2

9.64e-04291263IPR002017
DomainRecF/RecN/SMC_N

SMC2 SMC3

1.23e-0381262IPR003395
DomainSMC_N

SMC2 SMC3

1.23e-0381262PF02463
DomainSPEC

DRP2 SPTAN1 SYNE2

1.29e-03321263SM00150
DomainSpectrin/alpha-actinin

DRP2 SPTAN1 SYNE2

1.29e-03321263IPR018159
DomainIQ

MYH6 UBE3B IQCD IQCB1

1.35e-03711264PF00612
DomainARM-type_fold

MROH2A PIK3CA IQCB1 EIF4G1 CTNNBL1 UTP20 HECTD1 TARBP1

2.13e-033391268IPR016024
DomainIQ

MYH6 UBE3B IQCD IQCB1

2.20e-03811264SM00015
DomainKinesin-like_fam

KIF26A KIF26B KIF20B

3.04e-03431263IPR027640
DomainIQ_motif_EF-hand-BS

MYH6 UBE3B IQCD IQCB1

3.23e-03901264IPR000048
Domain-

KIF26A KIF26B KIF20B

3.24e-034412633.40.850.10
DomainKinesin

KIF26A KIF26B KIF20B

3.24e-03441263PF00225
DomainKISc

KIF26A KIF26B KIF20B

3.24e-03441263SM00129
DomainKINESIN_MOTOR_1

KIF26A KIF26B KIF20B

3.24e-03441263PS00411
DomainKinesin_motor_dom

KIF26A KIF26B KIF20B

3.24e-03441263IPR001752
DomainKINESIN_MOTOR_2

KIF26A KIF26B KIF20B

3.24e-03441263PS50067
DomainMed26

IWS1 MED26

3.35e-03131262PF08711
Domain-

IWS1 MED26

3.35e-031312621.20.930.10
DomainTFIIS_N

IWS1 MED26

3.35e-03131262PS51319
DomainCyt_P450_E_grp-I

CYP2A6 CYP2A7 CYP3A5

3.46e-03451263IPR002401
DomainIQ

MYH6 UBE3B IQCD IQCB1

3.63e-03931264PS50096
DomainEamA

SLC35E1 SLC35F5

3.90e-03141262PF00892
DomainP_typ_ATPase_c

ATP8B4 ATP8B2

3.90e-03141262IPR032630
DomainP-type_ATPase_N

ATP8B4 ATP8B2

3.90e-03141262IPR032631
DomainP-type_ATPase_IV

ATP8B4 ATP8B2

3.90e-03141262IPR006539
DomainTFIIS_N

IWS1 MED26

3.90e-03141262IPR017923
DomainEamA_dom

SLC35E1 SLC35F5

3.90e-03141262IPR000620
DomainPhoLip_ATPase_C

ATP8B4 ATP8B2

3.90e-03141262PF16212
DomainPhoLip_ATPase_N

ATP8B4 ATP8B2

3.90e-03141262PF16209
DomainSpectrin_alpha_SH3

SPTAN1 ITSN2

4.48e-03151262IPR013315
PathwayREACTOME_XENOBIOTICS

CYP2A6 CYP2A7 CYP3A4 CYP3A5

1.62e-0523964M5372
PathwayREACTOME_XENOBIOTICS

CYP2A6 CYP2A7 CYP3A4 CYP3A5

2.29e-0525964MM14846
Pubmed

Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals.

CYP2A6 CYP3A4 CYP3A5

1.99e-074129319225447
Pubmed

Establishment and analysis of a mouse model that regulates sex-related differences in liver drug metabolism.

CYP2A6 CYP2A7 CYP3A4 CYP3A5

2.39e-0715129429968852
Pubmed

Zinc Fingers and Homeoboxes 2 (Zhx2) Regulates Sexually Dimorphic Cyp Gene Expression in the Adult Mouse Liver.

CYP2A6 CYP2A7 CYP3A4 CYP3A5

4.14e-0717129427197076
Pubmed

CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, Haiti.

CYP2A6 CYP3A4 CYP3A5

4.96e-075129319659438
Pubmed

Molecular genetics of the human cytochrome P450 monooxygenase superfamily.

CYP2A6 CYP2A7 CYP3A4 CYP3A5

8.36e-072012949890157
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

GCFC2 ATRX SPTAN1 RFC1 BCOR IWS1 WWC2 PSIP1 ZNF644 EIF4G1 UTP20 CTNNA1 MARK2 SF3B2

1.20e-067741291415302935
Pubmed

Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.

CYP2A6 CYP3A4 CYP3A5

1.73e-067129318979093
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

ATRX POLA1 DHX37 RFC1 BCOR KIF20B IWS1 PSIP1 SMC3 ZNF644 KDM4A SENP7

2.99e-066081291236089195
Pubmed

Chromosomal assignments of genes coding for components of the mixed-function oxidase system in mice. Genetic localization of the cytochrome P-450PCN and P-450PB gene families and the nadph-cytochrome P-450 oxidoreductase and epoxide hydratase genes.

CYP2A6 CYP3A4 CYP3A5

4.12e-06912933917435
Pubmed

Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.

ATRX ORC3 POLA1 SPTAN1 SMC2 SMC3 EIF4G1 CTNNBL1 SF3B2

4.44e-06332129932786267
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

POLA1 SPTAN1 MRPL28 CPS1 RFC1 MAP7 SMC2 LETM1 IWS1 PSIP1 SMC3 SYNE2 EIF4G1 CTNNBL1 CTNNA1 HECTD1 TARBP1 SF3B2

5.11e-0614151291828515276
Pubmed

Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population.

CYP2A6 CYP3A4 CYP3A5

8.05e-0611129315469410
Pubmed

Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes.

CYP2A6 CYP3A4 CYP3A5

8.05e-0611129315039299
Pubmed

Effects of Genetic Polymorphism in CYP3A4 and CYP3A5 Genes on Tacrolimus Dose Among Kidney Transplant Recipients.

CYP3A4 CYP3A5

1.37e-052129227225724
Pubmed

The combination of CYP3A4*22 and CYP3A5*3 single-nucleotide polymorphisms determines tacrolimus dose requirement after kidney transplantation.

CYP3A4 CYP3A5

1.37e-052129228704257
Pubmed

Genotype-phenotype associations of cytochrome P450 3A4 and 3A5 polymorphism with midazolam clearance in vivo.

CYP3A4 CYP3A5

1.37e-052129215900284
Pubmed

Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.

CYP2A6 CYP2A7

1.37e-052129212325023
Pubmed

Genetic association in CYP3A4 and CYP3A5 genes elevate the risk of prostate cancer.

CYP3A4 CYP3A5

1.37e-052129236688864
Pubmed

Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin-induced muscle damage.

CYP3A4 CYP3A5

1.37e-052129215900215
Pubmed

Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes.

CYP3A4 CYP3A5

1.37e-052129231309254
Pubmed

Impact of CYP3A5 and CYP3A4 gene polymorphisms on dose requirement of calcineurin inhibitors, cyclosporine and tacrolimus, in renal allograft recipients of North India.

CYP3A4 CYP3A5

1.37e-052129219343327
Pubmed

CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease.

CYP3A4 CYP3A5

1.37e-052129219907160
Pubmed

CYP3A4*1G and CYP3A5*3 genetic polymorphisms alter the antihypertensive efficacy of amlodipine in patients with hypertension following renal transplantation
.

CYP3A4 CYP3A5

1.37e-052129227841150
Pubmed

Precision Dosing for Tacrolimus Using Genotypes and Clinical Factors in Kidney Transplant Recipients of European Ancestry.

CYP3A4 CYP3A5

1.37e-052129233512723
Pubmed

Relationship between In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Systemic Tacrolimus Metabolite/Parent Drug Ratio in Renal Transplant Recipients and Healthy Volunteers.

CYP3A4 CYP3A5

1.37e-052129230166405
Pubmed

Local retention versus systemic release of soluble VEGF receptor-1 are mediated by heparin-binding and regulated by heparanase.

FLT1 HPSE

1.37e-052129221415391
Pubmed

Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis.

CYP3A4 CYP3A5

1.37e-052129223459029
Pubmed

CYP3A4∗18B and CYP3A5∗3 polymorphisms contribute to pharmacokinetic variability of cyclosporine among healthy Chinese subjects.

CYP3A4 CYP3A5

1.37e-052129225976223
Pubmed

CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.

CYP2A6 CYP2A7

1.37e-052129216636685
Pubmed

The impact of cytochrome P450 3A genetic polymorphisms on tacrolimus pharmacokinetics in ulcerative colitis patients.

CYP3A4 CYP3A5

1.37e-052129233886687
Pubmed

Active-site differences between substrate-free and ritonavir-bound cytochrome P450 (CYP) 3A5 reveal plasticity differences between CYP3A5 and CYP3A4.

CYP3A4 CYP3A5

1.37e-052129230926609
Pubmed

Genetic diversity of CYP3A4 and CYP3A5 polymorphisms in North African populations from Morocco and Tunisia.

CYP3A4 CYP3A5

1.37e-052129225385241
Pubmed

CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population.

CYP3A4 CYP3A5

1.37e-052129215698606
Pubmed

CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer.

CYP3A4 CYP3A5

1.37e-052129214504207
Pubmed

Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women.

CYP3A4 CYP3A5

1.37e-052129214515058
Pubmed

The CYP3A4*1B allele increases risk for small cell lung cancer: effect of gender and smoking dose.

CYP3A4 CYP3A5

1.37e-052129214515059
Pubmed

Association between CYP3A4/CYP3A5 genetic polymorphisms and treatment outcomes of atorvastatin worldwide: is there enough research on the Egyptian population?

CYP3A4 CYP3A5

1.37e-052129237759317
Pubmed

Association of CYP3A4, CYP3A5 polymorphisms with lung cancer risk in Bangladeshi population.

CYP3A4 CYP3A5

1.37e-052129224085358
Pubmed

Recombinant CYP3A4*17 is defective in metabolizing the hypertensive drug nifedipine, and the CYP3A4*17 allele may occur on the same chromosome as CYP3A5*3, representing a new putative defective CYP3A haplotype.

CYP3A4 CYP3A5

1.37e-052129215634941
Pubmed

Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase.

CYP3A4 CYP3A5

1.37e-052129226615671
Pubmed

Drugs as CYP3A probes, inducers, and inhibitors.

CYP3A4 CYP3A5

1.37e-052129218058330
Pubmed

Comparative analysis of substrate and inhibitor interactions with CYP3A4 and CYP3A5.

CYP3A4 CYP3A5

1.37e-052129216684709
Pubmed

Comparison of catalytic properties of cytochromes P450 3A4 and 3A5 by molecular docking simulation.

CYP3A4 CYP3A5

1.37e-052129224484539
Pubmed

Assessment of the impact of CYP3A polymorphisms on the formation of α-hydroxytamoxifen and N-desmethyltamoxifen in human liver microsomes.

CYP3A4 CYP3A5

1.37e-052129222096084
Pubmed

Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study.

CYP3A4 CYP3A5

1.37e-052129224469018
Pubmed

Biosynthesis and Identification of Metabolites of Maraviroc and Their Use in Experiments to Delineate the Relative Contributions of Cytochrome P4503A4 versus 3A5.

CYP3A4 CYP3A5

1.37e-052129229475834
Pubmed

Association between the CYP3A4 and CYP3A5 polymorphisms and cancer risk: a meta-analysis and meta-regression.

CYP3A4 CYP3A5

1.37e-052129224989928
Pubmed

The Prognostic Role of CYP Enzyme in Kidney Transplantation: A Single Centre Experience.

CYP3A4 CYP3A5

1.37e-052129236396462
Pubmed

Influence of CYP3A5*3 polymorphism and interaction between CYP3A5*3 and CYP3A4*1G polymorphisms on post-operative fentanyl analgesia in Chinese patients undergoing gynaecological surgery.

CYP3A4 CYP3A5

1.37e-052129221513075
Pubmed

Decision tree-based modeling of androgen pathway genes and prostate cancer risk.

CYP3A4 CYP3A5

1.37e-052129221493872
Pubmed

CYP3A activity based on plasma 4β-hydroxycholesterol during the early postpartum period has an effect on the plasma disposition of amlodipine.

CYP3A4 CYP3A5

1.37e-052129226654672
Pubmed

Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects.

CYP3A4 CYP3A5

1.37e-052129215114431
Pubmed

Regulatory variants in a novel distal enhancer regulate the expression of CYP3A4 and CYP3A5.

CYP3A4 CYP3A5

1.37e-052129236045613
Pubmed

Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients.

CYP3A4 CYP3A5

1.37e-052129229160300
Pubmed

Amlodipine metabolism in human liver microsomes and roles of CYP3A4/5 in the dihydropyridine dehydrogenation.

CYP3A4 CYP3A5

1.37e-052129224301608
Pubmed

Screening CYP3A single nucleotide polymorphisms in a Han Chinese population with a genotyping chip.

CYP3A4 CYP3A5

1.37e-052129216207150
Pubmed

Discovery of a highly selective CYP3A4 inhibitor suitable for reaction phenotyping studies and differentiation of CYP3A4 and CYP3A5.

CYP3A4 CYP3A5

1.37e-052129222696420
Pubmed

CYP3A4/5 genotypes and age codetermine tacrolimus concentration and dosage in pediatric heart transplant recipients.

CYP3A4 CYP3A5

1.37e-052129235998509
Pubmed

Association of genotypes of the CYP3A cluster with midazolam disposition in vivo.

CYP3A4 CYP3A5

1.37e-052129219506580
Pubmed

CYP3A4*22 and CYP3A5*3 impact efficacy and safety of diazepam in patients with alcohol withdrawal syndrome.

CYP3A4 CYP3A5

1.37e-052129235471917
Pubmed

CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients.

CYP3A4 CYP3A5

1.37e-052129217495880
Pubmed

Association of CYP3A4/5 genotypes and expression with the survival of patients with neuroblastoma.

CYP3A4 CYP3A5

1.37e-052129225370902
Pubmed

Heparanase regulation of sFLT-1 release in trophoblasts in vitro.

FLT1 HPSE

1.37e-052129231327483
Pubmed

A case-control association study between the CYP3A4 and CYP3A5 genes and schizophrenia in the Chinese Han population.

CYP3A4 CYP3A5

1.37e-052129219591893
Pubmed

CYP3A4 and CYP3A5 Expression is Regulated by CYP3A4*1G in CRISPR/Cas9-Edited HepG2 Cells.

CYP3A4 CYP3A5

1.37e-052129236623883
Pubmed

Association of CYP3A4*1G and CYP3A5*3 With the 1-year Outcome of Acute Ischemic Stroke in the Han Chinese Population.

CYP3A4 CYP3A5

1.37e-052129231064695
Pubmed

The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes.

CYP2A6 CYP2A7

1.37e-05212922322567
Pubmed

Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients.

CYP3A4 CYP3A5

1.37e-052129226521259
Pubmed

Long-Term Stability of Cryopreserved Human Hepatocytes: Evaluation of Phase I and II Drug-Metabolizing Enzyme Activities and CYP3A4/5 Induction for More than a Decade.

CYP3A4 CYP3A5

1.37e-052129228411281
Pubmed

Associations of the CYP3A5*3 and CYP3A4*1G polymorphisms with the pharmacokinetics of oral midazolam and the urinary 6β-hydroxycortisol/cortisol ratio as markers of CYP3A activity in healthy male Chinese.

CYP3A4 CYP3A5

1.37e-052129227511886
Pubmed

Thinking and doing: the effects of dopamine and oxytocin genes and executive function on mothering behaviours.

DRD1 OXTR

1.37e-052129227620964
Pubmed

Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach.

CYP3A4 CYP3A5

1.37e-052129225141896
Pubmed

Expression and alternative splicing of the cytochrome P-450 CYP2A7.

CYP2A6 CYP2A7

1.37e-05212927864805
Pubmed

Differential expression of human cytochrome P450 enzymes from the CYP3A subfamily in the brains of alcoholic subjects and drug-free controls.

CYP3A4 CYP3A5

1.37e-052129223491640
Pubmed

Cytochrome P450 3A-dependent metabolism of a potent and selective gamma-aminobutyric acid Aalpha2/3 receptor agonist in vitro: involvement of cytochrome P450 3A5 displaying biphasic kinetics.

CYP3A4 CYP3A5

1.37e-052129217460031
Pubmed

The rs776746 variant of CYP3A5 is associated with intravenous midazolam plasma levels and higher clearance in critically ill Mexican paediatric patients.

CYP3A4 CYP3A5

1.37e-052129233638195
Pubmed

Study the polymorphism of CYP3A5 and CYP3A4 loci in Iranian population with laryngeal squamous cell carcinoma.

CYP3A4 CYP3A5

1.37e-052129221380731
Pubmed

Influence of CYP3A polymorphisms on tacrolimus pharmacokinetics in kidney transplant recipients.

CYP3A4 CYP3A5

1.37e-052129232843687
Pubmed

Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients.

CYP3A4 CYP3A5

1.37e-052129217605821
Pubmed

Expression and enzyme activity of cytochrome P450 enzymes CYP3A4 and CYP3A5 in human skin and tissue-engineered skin equivalents.

CYP3A4 CYP3A5

1.37e-052129229227563
Pubmed

Physical activity associates empathy in Japanese young adults with specific gene variations of oxytocin receptor and vasopressin V1B receptor.

AVPR1B OXTR

1.37e-052129235905808
Pubmed

[Influence of CYP3A4/5 polymorphisms in the pharmacokinetics of levonorgestrel: a pilot study].

CYP3A4 CYP3A5

1.37e-052129223715232
Pubmed

Evaluating the Impacts of CYP3A4*1B and CYP3A5*3 Variations on Pharmacokinetic Behavior and Clinical Outcomes in Multiple Myeloma Patients With Autologous Stem Cell Transplant.

CYP3A4 CYP3A5

1.37e-052129236581339
Pubmed

Selective mechanism-based inactivation of CYP3A4 by CYP3cide (PF-04981517) and its utility as an in vitro tool for delineating the relative roles of CYP3A4 versus CYP3A5 in the metabolism of drugs.

CYP3A4 CYP3A5

1.37e-052129222645092
Pubmed

CYP3A4 and CYP3A5 genotyping by Pyrosequencing.

CYP3A4 CYP3A5

1.37e-052129215882469
Pubmed

Mouse RAD54 affects DNA double-strand break repair and sister chromatid exchange.

ATRX RAD54L

1.37e-052129210757799
Pubmed

Influence of CYP3A4*22 and CYP3A5*3 combined genotypes on tacrolimus dose requirements in Egyptian renal transplant patients.

CYP3A4 CYP3A5

1.37e-052129236379901
Pubmed

Induction of hepatic CYP3A enzymes by pregnancy-related hormones: studies in human hepatocytes and hepatic cell lines.

CYP3A4 CYP3A5

1.37e-052129223223499
Pubmed

The relative contributions of CYP3A4 and CYP3A5 to the metabolism of vinorelbine.

CYP3A4 CYP3A5

1.37e-052129223780963
Pubmed

Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?

CYP3A4 CYP3A5

1.37e-052129220630055
Pubmed

[Effect of CYP3A4*18B, CYP3A5*3 gene polymorphism on dosage and concentration of tacrolimus in renal transplant patients].

CYP3A4 CYP3A5

1.37e-052129222993851
Pubmed

Genotype-phenotype variability in human CYP3A locus in Nepalese people residing in Bangladesh.

CYP3A4 CYP3A5

1.37e-052129223320986
Pubmed

Functionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping tests.

CYP3A4 CYP3A5

1.37e-052129216004554
Pubmed

Association of CYP3A4*18B and CYP3A5*3 polymorphism with cyclosporine-related liver injury in Chinese renal transplant recipients.

CYP3A4 CYP3A5

1.37e-052129224691060
Pubmed

Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients.

CYP3A4 CYP3A5

1.37e-052129216243813
Pubmed

Sequence diversity and haplotype structure at the human CYP3A cluster.

TRIM4 CYP3A4 CYP3A5

1.39e-0513129316314882
Pubmed

HectD1 controls hematopoietic stem cell regeneration by coordinating ribosome assembly and protein synthesis.

PSMD12 RFC1 SMC2 EIF4G1 HECTD1

1.88e-0587129533711283
Pubmed

GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system.

SPTAN1 E2F7 RFC1 MAP7 SMC2 EIF4G1 SF3B2

1.97e-05221129729991511
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

GPBP1 KIF26B SPTAN1 MAP7 WWC2 SYNE2 IQCB1 EIF4G1 MARK2 CAMSAP1 HECTD1 NOS1AP OTOG

2.01e-058611291336931259
Pubmed

SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice.

ORC3 DHX37 RFC1 SMC2 SMC3 ZNF644

2.14e-05150129630154076
Cytoband7q21.1

CYP3A4 CYP3A5

2.17e-04812927q21.1
GeneFamilyArginine vasopressin and oxytocin receptors

AVPR1B OXTR

1.53e-044922259
GeneFamilyStructural maintenance of chromosomes proteins|Cohesin complex

SMC2 SMC3

5.29e-047922761
GeneFamilyCytochrome P450 family 3

CYP3A4 CYP3A5

7.03e-0489221002
GeneFamilyMannosyl-glycoprotein N-acetylglucosaminyltransferases

MGAT4D MGAT5B

9.01e-049922435
GeneFamilyKinesins|Pleckstrin homology domain containing

KIF26A KIF26B KIF20B

1.65e-0346923622
GeneFamilyATPase phospholipid transporting

ATP8B4 ATP8B2

2.58e-03159221210
GeneFamilySolute carriers

SLC35E1 SLC26A9 SLC22A24 SLC35F5 SLC9A3 SLCO1C1 SLC27A5

4.02e-03395927752
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

GPBP1 ORC3 PSMD12 RFC1 SMC2 KIF20B IWS1 PIEZO2 SMC3 PIK3CA ZNF644 SYNE2 ITSN2 HECTD1

4.16e-0665612814M18979
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_MedNas_2500_K1

GCFC2 ATRX ORC3 POLA1 LAMA1 E2F7 FAM171B SMC2 KIF20B RND3 PSIP1 SMC3 WDCP ZNF644 SYNE2 DNAI4 CAMSAP1 TSLP

3.93e-05106012318facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#1_top-relative-expression-ranked_1000

KIF26A FAM171B RND3 CNTNAP4 KCNQ2 CNTN3 KCNIP4 RAD54L

3.93e-052171238DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k1_1000
CoexpressionAtlasalpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3

POLA1 LONRF1 MROH2A SMC2 TERF1 KIF20B CD4 DNAI4 RAD54L DNTT

1.09e-0439812310GSM399397_500
CoexpressionAtlasPlasmacytoid, DC.pDC.8-.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3

HPSE RND3 CD4 KYNU DNTT

1.36e-04851235GSM605843_100
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500

POLA1 FAM171B MAP7 KIF20B IWS1 BMPR1B SMC3 SYNE2 CNTNAP4 UTP20 MGAT5B

1.41e-0449312311Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500
CoexpressionAtlasPlasmacytoid, DC.pDC.8+.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3

HPSE RND3 CD4 KYNU DNTT

1.44e-04861235GSM605840_100
CoexpressionAtlasPlasmacytoid, DC.pDC.8+.SLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-3

HPSE RND3 CD4 KYNU DNTT

1.52e-04871235GSM854299_100
CoexpressionAtlasPlasmacytoid, DC.pDC.8+.MLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-2

HPSE RND3 CD4 KYNU DNTT

1.52e-04871235GSM854297_100
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DRP2 KIF26B MROH2A LAMA1 CPS1 PIEZO2 CNTNAP4 KCNQ2 OTOG

3.30e-0918412892cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DRP2 KIF26B MROH2A LAMA1 CPS1 PIEZO2 CNTNAP4 KCNQ2 OTOG

3.30e-091841289ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DRP2 KIF26B MROH2A LAMA1 CPS1 PIEZO2 CNTNAP4 KCNQ2 OTOG

3.30e-0918412892b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellCOVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

CYP2A7 FLT1 RARB CHRM3 SYNE2 KCNIP4 CDRT15L2 OTOG

9.88e-091451288afed661aef990edb8e7012ab67ace56443520c9f
ToppCell(11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition

ATRX PSMD12 PTPN18 KIF20B IWS1 SMC3 ZNF644 SYNE2

1.11e-07198128876d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

ATRX RFC1 PTPN18 SMC3 ZNF644 SYNE2 ITSN2 ANKRD36

1.16e-071991288c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCellAdult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor

ARHGAP42 CYP2A6 CYP2A7 RARB BMPR1B SYNE2 CNTN3

8.52e-07178128735a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DCDC1 LAMA1 DNAH14 SLC35F5 SYNE2 DNAI4 NFAT5

1.36e-061911287d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCellChildren_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

ARHGAP42 CYP2A6 CYP2A7 RARB BMPR1B CNTN3 NOS1AP

1.36e-06191128723776c7302cead3881b39127398f3b3e0d27885e
ToppCellEpithelial-club_cell|World / Lineage, Cell type, age group and donor

ARHGAP42 CYP2A6 CYP2A7 MAP7 BMPR1B CNTN3 NOS1AP

1.46e-0619312872bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL16A1 POLA1 RFC1 FAM171B SMC2 RND3 PSIP1

1.51e-061941287af4bbb2deb5a3913eb58990690fc3c62fbc3708c
ToppCellChildren_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

ARHGAP42 CYP2A6 CYP2A7 RARB BMPR1B SYNE2 CNTN3

1.57e-061951287dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCellParenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ARHGAP42 CYP2A6 RARB BMPR1B SYNE2 CNTN3 NOS1AP

1.73e-0619812871408e02e053ad3406229bfe8189da03be6366e81
ToppCell(00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition

ATRX PSMD12 RFC1 PTPN18 IWS1 SMC3 SYNE2

1.79e-06199128719674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell(01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition

ATRX PSMD12 RFC1 PTPN18 SMC3 ZNF644 SYNE2

1.79e-061991287a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCellParenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

POLA1 BRME1 E2F7 SMC2 KIF20B ANKRD34B RAD54L

1.85e-062001287af3dc76b4507bf4edd265169f5dfbbb8a19eb394
ToppCellFetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CYP2A6 CYP2A7 MAP7 BMPR1B OXTR NOS1AP

7.50e-0616212865c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

AVPR1B POLA1 BRME1 E2F7 HPSE RAD54L

9.54e-061691286121768fc51fc3441ec725346a1bbe29e21d05971
ToppCelldroplet-Lung-nan-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GRM8 HPSE CMTM1 KDM4A KYNU DNTT

1.09e-0517312861b9b4e165121b08ef15a93fca6bea875cae69f19
ToppCelldroplet-Lung-nan-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GRM8 HPSE CMTM1 KDM4A KYNU DNTT

1.09e-051731286c25f24d7b672c9686d31ebc8d263042282f520fd
ToppCellControl-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class

ARHGAP42 CYP2A6 CYP2A7 BMPR1B KYNU NOS1AP

1.59e-0518512866814b3c94c7558443c038a227b5c8563d2cfeac4
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

LAMA1 DNAH14 CCDC148 SLC9A3 KCNIP4 NOS1AP

1.59e-051851286898a093757f86be3e18d2ef1f16a71f50ef81dc3
ToppCellSubstantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

KIF26B ANKRD34B PIK3CA CNTNAP4 KCNQ2 KCNIP4

1.64e-0518612869d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce
ToppCellControl-Epithelial-Club|World / Disease state, Lineage and Cell class

ARHGAP42 CYP2A6 CYP2A7 MAP7 BMPR1B NOS1AP

1.64e-0518612869798428691408e17ff2af2fe2d1b345f074d67e4
ToppCell5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FLT1 FAM171B CHRM3 PIEZO2 TSLP RAD54L

1.75e-051881286524d1d928c9386acf20e53d31894107dd7290dc7
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

GPBP1 CBLB ZNF644 SYNE2 ANKRD36 NFAT5

1.75e-051881286ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FLT1 FAM171B CHRM3 PIEZO2 TSLP RAD54L

1.75e-0518812861b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5
ToppCell5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FLT1 FAM171B CHRM3 PIEZO2 TSLP RAD54L

1.75e-051881286cd2d1f8e43c252dd8730a5758458ef63e7ffc836
ToppCell5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FLT1 FAM171B CHRM3 PIEZO2 TSLP RAD54L

1.75e-051881286f5a2f324f3f6c5078d57130392d3f1ba74f29094
ToppCell5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FLT1 FAM171B CHRM3 PIEZO2 TSLP RAD54L

1.75e-0518812866c9d5e4014f807149328ff4eabd5e86dfe18094d
ToppCellrenal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

LAMA1 CCDC148 BMPR1B SLC9A3 KCNIP4 NFAT5

1.80e-051891286830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGAP42 COL16A1 RARB KIF26B RND3 PIEZO2

1.85e-05190128645df8fee00f8949937863159d7aa042e72748d9b
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

MAP7 BMPR1B KCNIP4 CTNNA1 NFAT5 NOS1AP

1.97e-051921286f7e7491426bbd6ed29a465b58bf67acb93dbb90a
ToppCellControl-Epithelial-Club|Control / Disease state, Lineage and Cell class

ARHGAP42 CYP2A6 CYP2A7 MAP7 BMPR1B NOS1AP

1.97e-051921286d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGAP42 COL16A1 RARB KIF26B RND3 PIEZO2

1.97e-051921286df1545670370fb1010c567cd059c2783eab315f7
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

MAP7 GRM8 BMPR1B KCNIP4 NFAT5 NOS1AP

2.09e-05194128646070fbb0ee0eb9e1801c43b73a15707471056dc
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

MAP7 GRM8 BMPR1B KCNIP4 NFAT5 NOS1AP

2.09e-051941286abacb6a8d7a9003f2f6c2be0305507f1c1c50347
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DCDC1 GRM8 SLC35F5 SYNE2 DNAI4 KCNIP4

2.09e-051941286e577d9e88390b36b5a09b97fe1026089892275a3
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP42 COL16A1 RARB KIF26B BMPR1B PIEZO2

2.15e-051951286d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP42 COL16A1 RARB BMPR1B PIEZO2 SLCO1C1

2.15e-051951286803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ATRX CBLB KIF20B PIK3CA SYNE2 ANKRD36

2.15e-051951286ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP42 COL16A1 RARB BMPR1B PIEZO2 SLCO1C1

2.15e-0519512864f70157d42a16ff0259bc24a62803c4df4285c44
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP42 COL16A1 RARB KIF26B BMPR1B PIEZO2

2.21e-051961286a12dd986df65c36f248cf10815c3b8b6238613b0
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LAMA1 MAP7 DNAH14 CCDC148 SLC35F5 KCNIP4

2.21e-0519612866ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP42 COL16A1 RARB KIF26B BMPR1B PIEZO2

2.21e-0519612863e6803587d8566fd08cb8b290be3b6461743d79c
ToppCellCOVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type

COL16A1 KIF26B E2F7 KIF20B PIEZO2 RAD54L

2.21e-051961286ca91d5e325875e7444809b80fcbd491d8899ea36
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP42 COL16A1 RARB KIF26B BMPR1B PIEZO2

2.27e-0519712866d027119a5f7ca2aac1b10837e43f9a2bb54db85
ToppCellParenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

BRME1 E2F7 SMC2 KIF20B KYNU RAD54L

2.27e-051971286d669d90c3f9e98b41bcbc49dbdc5698e0b42597c
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP42 COL16A1 RARB KIF26B BMPR1B PIEZO2

2.27e-051971286b349f8e96d61a4c296af64711e11fc44459a9413
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP42 COL16A1 RARB KIF26B BMPR1B PIEZO2

2.27e-051971286c2e390653d5dee7e731c1840cfdab41987dede9b
ToppCellNS-critical-LOC-Lymphoid-CTL|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CBLB ATP8B2 CD4 PSIP1 SYNE2 ANKRD36

2.34e-051981286e2acb074142aa62c763139bbcf36f6f85038d04b
ToppCellParenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ARHGAP42 CYP2A6 RARB BMPR1B CNTN3 NOS1AP

2.34e-051981286af399569c718f5fd971d73a7926768c9311002a3
ToppCellParenchymal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CYP2A6 FAM171B KIF20B BMPR1B CNTN3 RAD54L

2.34e-051981286d5e125f0c4f41b47d567568d0838adcca7655f6d
ToppCell(04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition

ATRX PSMD12 PTPN18 IWS1 SMC3 SYNE2

2.41e-05199128653ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell(09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition

ATRX PSMD12 PTPN18 IWS1 SMC3 SYNE2

2.41e-051991286fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

SMC2 TERF1 PSIP1 SMC3 SYNE2 CTNNBL1

2.41e-051991286dadee9fc6ce4f4bdb19d29326889316443dda0cb
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

FLT1 SPTAN1 CHRM3 OXTR SYNE2 SLC27A5

2.47e-05200128677ae679c35d3b9e2b620f34129f3a8d47e922c65
ToppCellControl_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type

FLT1 CHRM3 OXTR SYNE2 ITSN2 CNTNAP4

2.47e-05200128665b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Krt80|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

RARB KIF26A GRM8 ANKRD34B KCNG1

5.47e-05141128540ef6d792e11fe10963d64eb0b606b90556c1a70
ToppCellHippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32

AVPR1B CHRM3 KCNG1 KCNIP4 NOS1AP

6.66e-0514712858f725ff8fb4ced5db2643e80669d3f7945b820ab
ToppCell10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue

CPS1 CCDC148 BMPR1B SYNE2 ANKRD36

8.82e-05156128510d191e29b16cae8238e8df6c0ff38882253f34e
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 SMC2 CHRM3 KIF20B MGAT5B

9.94e-051601285830e3ef8c9708d25872c3052a0b2682fa9372111
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MROH2A LAMA1 CPS1 CNTNAP4 CNTN3

9.94e-051601285c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCellfacs-Heart-RV-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH6 MROH2A LRFN5 CNTNAP4 DNTT

9.94e-05160128541d6c811c445c0ba9b6a2deb10a3b6b793172582
ToppCellfacs-Heart-RV-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH6 MROH2A LRFN5 CNTNAP4 DNTT

9.94e-051601285c1d03c0ac9c12615a06499209fcdf18e9b6f1fba
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MROH2A LAMA1 CPS1 CNTNAP4 CNTN3

9.94e-05160128525c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCellfacs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ADCY10 AVPR1B CPS1 CNTN3 CDH12

1.05e-041621285bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue

FLT1 ATP8B2 CCDC148 CD4 SENP7

1.08e-0416312854104d3b9748b39cb0744c9be76db21bdda566a0d
ToppCelldroplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GRM8 HPSE CMTM1 KYNU DNTT

1.12e-041641285cfe07a1ebed8aecb08d0476db71fe314998d54aa
ToppCelldroplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GRM8 HPSE CMTM1 KYNU DNTT

1.12e-0416412856d331e74efecb4733d87653f86cd67247be05025
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

POLA1 NPSR1 BRME1 E2F7 RAD54L

1.28e-041691285e7514956b2e4298222ec443f98b2f5289451786e
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

ARHGAP42 RARB WWC2 BMPR1B SYNE2

1.32e-041701285a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCellImmune_cells-Dendritic_cells|World / Lineage and Cell class

GRM8 HPSE RND3 CD4 KYNU

1.32e-041701285094dc211d80c89ecb1010855f1fe6eeb71bf0e20
ToppCellStriatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4-POLYDENDROCYTE_(Rostral-�migratory_stream-�(RMS)_(Stmn2))|Striatum / BrainAtlas - Mouse McCarroll V32

E2F7 TMC3 CMTM1 SLC27A5

1.32e-049012847efc3437489c8587b9805547da1095f50d20cf6d
ToppCelldroplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

POLA1 SLC26A9 SMC2 KIF20B RAD54L

1.36e-0417112851eebd7138c3b20ddc1104f21615f9df0e776bbe6
ToppCellP15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

POLA1 DHX37 E2F7 SMC2 RAD54L

1.39e-0417212857c238a7375341d4647ba7274d93fddfb6fae7ce4
ToppCell10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

FAM171B MAP7 CHRM3 DNAH14 TARBP1

1.43e-04173128534357f0e22c4b6d84582492c82c1ea733ca8477d
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

POLA1 E2F7 SMC2 SMC3 RAD54L

1.47e-041741285c988471207ba06195bc3e41056435e8c31c20bbe
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SLC22A24 GRM8 DNAH14 BMPR1B CNTN3

1.47e-0417412852947e5906b172d149412fa4e77476fce4ea695d2
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LAMA1 DNAH14 CCDC148 SLC9A3 NOS1AP

1.51e-041751285e5467dacf81f1f913b1719931cf1a7331434a7e7
ToppCelldroplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 KIF26A E2F7 CNTNAP4 DNAI4

1.55e-04176128527e5115fae5f0f63b333bc99fbf6a6d4c9182c46
ToppCellCOVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type

CYP2A6 CYP3A4 CYP3A5 AVPR1B CPS1

1.55e-041761285b6497324e3e52f514ce556a3fa0c3011c45dcc7b
ToppCelldroplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 ATRX SMC3 SYNE2 ITSN2

1.64e-04178128501dafd19de04eff459253eaa9a35debf8f3deedf
ToppCellCOVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type

CYP3A5 KIF26B LRFN5 SYNE2 KCNIP4

1.64e-041781285544379f5a6145429762258d426b876bb36c112f5
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ARHGAP42 POLA1 RFC1 SMC2 PSIP1

1.68e-041791285ff678e2f33c914e3dd0f338ada25f506c3e3c980
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP42 CYP3A5 SLC22A24 ANKRD34B C10orf120

1.68e-04179128558ae5a97fe2a14e1c6fdeb886397eb06fdaf0428
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

AVPR1B POLA1 E2F7 OR2T10 RAD54L

1.68e-04179128580112c686a8f85ad5e3cda6e3f3d3d51cf688092
ToppCelldroplet-Marrow-nan-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GRM8 RND3 CD4 KYNU DNTT

1.72e-041801285df60970520fba2ac0639faa54096766d07418ca4
ToppCellfacs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GRM8 RND3 CD4 KYNU DNTT

1.77e-041811285782716b8b1d447d2bbe09a693fa5ed7ebeac0efb
ToppCellCOVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

FLT1 CYP3A5 GRM8 CHRM3 SYNE2

1.77e-041811285c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCellfacs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GRM8 RND3 CD4 KYNU DNTT

1.77e-041811285e2481291c236105774c53883e6f20da11941df9b
ToppCellfacs-Marrow-B-cells-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GRM8 RND3 CD4 SYNE2 DNTT

1.77e-041811285e6c78038b14100e0c9c6fe25e8f0b75c02c33549
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DRD1 RARB CD4 KCNG1 KCNQ2

1.81e-041821285d41ff834b8fc1d0e23cac7ae261de5f72874e462
ToppCellImmune_cells-Dendritic_cells|Immune_cells / Lineage and Cell class

GRM8 HPSE RND3 CD4 KYNU

1.81e-04182128599c7d4f1e7cd745643ba64b59190113bcd4e348e
ToppCellChildren_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

ARHGAP42 RARB BMPR1B CNTN3 NOS1AP

1.81e-041821285215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DRD1 RARB CD4 KCNG1 KCNQ2

1.81e-0418212856cde859edfe7607bd7ada89d20258413d06f4207
ToppCellCOVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type

OR2T10 MAP7 SLC22A24 SYNE2 KCNIP4

1.86e-0418312856878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCellCalu_3-infected|Calu_3 / Cell line, Condition and Strain

GPBP1 RND3 ZNF644 SYNE2 NFAT5

1.86e-0418312858f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCellPosterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Pdyn_(Neuron.Gad1Gad2.Sst-Pdyn)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

MROH2A HPSE DNTT

1.91e-043912838b5d15f979a92799a9e77f1b501d3c4fa4e8695a
ToppCellPosterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Pdyn_(Neuron.Gad1Gad2.Sst-Pdyn)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

MROH2A HPSE DNTT

1.91e-04391283a24eb4c26344c5c97bbf39a1adc56ee34013dc4f
Drug3'-amino-3'-deoxythymidine

CYP2A6 FLT1 CYP3A4 CYP3A5 POLA1

1.67e-07231295CID000108074
DrugN-ethyl-3-toluamide

CYP2A6 CYP3A4 CYP3A5

7.08e-0741293ctd:C454678
Druglanosol

CYP2A6 CYP3A4 CYP3A5

3.51e-0661293CID000078659
Drugclimbazole

CYP3A4 CYP3A5 KCNG1

3.51e-0661293CID000037907
Drugcarbosulfan

CYP2A6 CYP3A4 CYP3A5

3.51e-0661293ctd:C035038
Drug4-formylbiphenyl

CYP2A6 CYP3A4 CYP3A5

6.12e-0671293CID000076689
Drug4-vinylcyclohexene

CYP2A6 CYP3A4 CYP3A5

6.12e-0671293CID000007499
Drug3-hydroxycoumarin

CYP2A6 CYP3A4 CYP3A5

6.12e-0671293CID000013650
Drugnafimidone

CYP2A6 CYP3A4 CYP3A5

9.75e-0681293CID000051199
Drugprecocene I

CYP2A6 CYP3A4 CYP3A5

9.75e-0681293CID000028619
Drugcoumarin 3,4-epoxide

CYP2A6 CYP3A4 CYP3A5

9.75e-0681293CID000126771
DrugF13-3

CYP2A6 CYP3A4 CYP3A5

1.46e-0591293CID000092758
Drug2-isopropenyloxirane

CYP2A6 CYP3A4 CYP3A5

1.46e-0591293CID000154909
Drugphenylcyclopropane

CYP2A6 CYP3A4 CYP3A5

1.46e-0591293CID000070112
DrugBP-9,10-oxide

CYP2A6 CYP2A7 CYP3A4 CYP3A5

1.56e-05271294CID000037456
DrugBrn 4136738

CYP2A6 CYP2A7 CYP3A4 CYP3A5

1.56e-05271294CID000050331
DrugC14845

CYP2A6 CYP2A7 CYP3A4 CYP3A5

1.56e-05271294CID011954064
Drug1,2-dihydroxynaphthalene

CYP2A6 CYP2A7 CYP3A4 CYP3A5 CTNNBL1

1.79e-05571295CID000011318
Drug9-OH-BaP-4,5-oxide

CYP2A6 CYP2A7 CYP3A4 CYP3A5

1.81e-05281294CID000115064
DrugCelsior

CYP2A6 CYP3A4 CYP3A5

2.07e-05101293ctd:C088453
Drugalpha-hydroxyalprazolam

CYP3A4 CYP3A5 HPSE

2.07e-05101293CID000162244
DrugAHMA

CYP2A6 CYP3A4 CYP3A5

2.07e-05101293CID000216240
DrugYM17E

CYP2A6 CYP3A4 CYP3A5

2.07e-05101293CID000180288
Drug19-hydroxytestosterone

CYP2A6 CYP2A7 CYP3A4 CYP3A5

2.40e-05301294CID000150968
Drug11-H-14,15-EETA

CYP2A6 CYP2A7 CYP3A4 CYP3A5

2.40e-05301294CID011954058
Drugsphondin

CYP2A6 CYP3A4 CYP3A5

2.84e-05111293CID000108104
Drugisoprene oxide

CYP2A6 CYP3A4 CYP3A5

2.84e-05111293CID000092166
DrugTicalopride

CYP2A6 CYP3A4 CYP3A5

2.84e-05111293CID000216236
DrugBP-7,8-oxide

CYP2A6 CYP2A7 CYP3A4 CYP3A5

3.13e-05321294CID000037455
DrugSpiro[naphthalene-2(3h),3'(10'h)-Pentaleno[1,2-B]naphthalene]-3,10'-Dione, 2'-[(2-Amino-2-Deoxy-B-D-Gulopyranosyl)oxy]-1,1',2',3'a,4,10'a-Hexahydro-,(2'r,3'as,10'ar)-(9ci)

AMPD3 FLT1 CYP3A4 TERF1 CD4

3.15e-05641295CID005288040
DrugCTK2G6074

CYP2A6 CYP3A4

3.19e-0521292CID011263510
Drug4-hydroxymidazolam

CYP3A4 CYP3A5

3.19e-0521292ctd:C042940
DrugNsc70535

CYP2A6 CYP3A5

3.19e-0521292CID006847048
Drugnorverapamil

CYP3A4 CYP3A5

3.19e-0521292ctd:C016904
Drug5,6-dihydro-2H-pyran-2-one

CYP3A4 CYP3A5

3.19e-0521292CID000520660
Drugnotopterol

CYP3A4 CYP3A5

3.19e-0521292CID005320227
DrugN-acetyl-S--(1,2,3,4,4-pentachlorobutadienyl)cysteine sulfoxide

CYP3A4 CYP3A5

3.19e-0521292ctd:C114289
Drug3-(3-thienyl)pyridine

CYP2A6 CYP3A4

3.19e-0521292CID000595254
DrugCTK3D1374

CYP2A6 CYP3A4

3.19e-0521292CID011148236
Drugnicotelline

CYP2A6 CYP3A5

3.19e-0521292CID000068123
Drug7-aminocoumarin

CYP2A6 CYP3A5

3.19e-0521292CID000189055
DrugCTK2I3856

CYP2A6 CYP3A4

3.19e-0521292CID011993867
DrugAC1Q3D7R

CYP2A6 CYP3A4

3.19e-0521292CID011993871
DrugCTK2I3857

CYP2A6 CYP3A4

3.19e-0521292CID011993873
DrugCTK2I3859

CYP2A6 CYP3A4

3.19e-0521292CID011993872
DrugKB-02207

CYP2A6 CYP3A4

3.19e-0521292CID011206290
Drug4-hydroxy-4-(3-pyridyl)butanal

CYP2A6 CYP3A5

3.19e-0521292CID000188122
Drug6 beta-hydroxytestosterone

CYP3A4 CYP3A5

3.19e-0521292ctd:C025591
Drug2,3'-bipyridyl

CYP2A6 CYP3A5

3.19e-0521292CID000011389
Drug4,4'-methanol-bisbenzonitrile

CYP2A6 CYP3A4

3.19e-0521292ctd:C543441
DrugCQA 206-291

CYP3A4 CYP3A5

3.19e-0521292ctd:C059483
Drug4-methyl-2-(3-pyridyl)thiazole

CYP2A6 CYP3A4

3.19e-0521292CID001201554
Drugfructus schizandrae, radix ginseng, radix ophiopogonis drug combination

CYP3A4 CYP3A5

3.19e-0521292ctd:C009252
Drugnicotyrine

CYP2A6 CYP3A5

3.19e-0521292CID000010249
DrugAC1L7R8G

CYP3A4 CYP3A5 POLA1

3.77e-05121293CID000315219
Drug16 alpha-hydroxytestosterone

CYP2A6 CYP3A4 CYP3A5

3.77e-05121293CID000065545
Drug9-anthraldehyde

CYP2A6 CYP3A4 CYP3A5

3.77e-05121293CID000069504
Drugc600

CYP3A4 POLA1 SMC3

3.77e-05121293CID000070602
Drug1,3-dimethylpurine-2,6,8-trione

CYP2A6 CYP3A4 CYP3A5

3.77e-05121293CID014754220
Drug3-methyleneindolenine

CYP2A6 CYP3A4 CYP3A5

3.77e-05121293CID000170404
DrugLu 25-109

CYP2A6 CYP3A4 CYP3A5

3.77e-05121293CID000178029
Drug12(13)-EpOME

CYP2A6 CYP2A7 CYP3A4 CYP3A5

4.00e-05341294CID000001416
DrugTCEO

CYP2A6 CYP2A7 CYP3A4 CYP3A5

4.00e-05341294CID000028167
DrugAC1O5XSP

CYP2A6 CYP2A7 CYP3A4 CYP3A5

4.00e-05341294CID006442739
DrugAC1L1CJI

CYP2A6 CYP2A7 CYP3A4 CYP3A5

4.49e-05351294CID000001929
Drug4-bromophenol

CYP2A6 CYP2A7 CYP3A4 CYP3A5 CD4

4.87e-05701295CID000007808
Drug2-chloro-1,1-difluoroethene

CYP2A6 CYP3A4 CYP3A5

4.88e-05131293CID000009664
Drug1'-hydroxymidazolam

CYP2A6 CYP3A4 CYP3A5

4.88e-05131293CID000107917
Drug5-hydroxyomeprazole

CYP2A6 CYP3A4 CYP3A5

4.88e-05131293CID000119560
Drug15-H-11,12-EETA

CYP2A6 CYP2A7 CYP3A4 CYP3A5

5.03e-05361294CID011954042
DrugAC1L3NGJ

CYP2A6 CYP2A7 CYP3A4 CYP3A5

5.03e-05361294CID000092121
Drughexamethylphosphoramide

CYP2A6 CYP2A7 CYP3A5 SMC2

5.03e-05361294CID000012679
Drugpromazine

DRD1 CYP3A4 CYP3A5 CHRM3

5.62e-05371294CID000004926
Drugchloral

CYP2A6 CYP2A7 DRD1 CYP3A4 CYP3A5

5.96e-05731295CID000006407
Drugallyl methyl sulfide

CYP2A6 CYP3A4 CYP3A5

6.18e-05141293CID000066282
Drug7-BFC

CYP2A6 CYP3A4 CYP3A5

6.18e-05141293CID000848780
DrugN-nitrosomethylaniline

CYP2A6 CYP2A7 CYP3A5

6.18e-05141293CID000011957
DrugAC1O5K1I

CYP2A6 CYP3A4 OXTR

6.18e-05141293CID006435567
Drug7-hydroxycoumarin

CYP2A6 CYP2A7 CYP3A4 CYP3A5 HPSE

6.79e-05751295CID005281426
Drugdebrisoquine

CYP2A6 CYP2A7 CYP3A4 CYP3A5 SMC3

6.79e-05751295CID000002965
Drug11,14,15-THET

CYP2A6 CYP2A7 CYP3A4 CYP3A5

6.94e-05391294CID006439531
Drug2'-(glutathion-S-yl)-deschlorodiclofenac

CYP2A6 CYP3A4 CYP3A5

7.69e-05151293ctd:C586542
DrugFdTTP

FLT1 POLA1 DNTT

7.69e-05151293CID000162005
Drugaflatoxin Q1

CYP2A6 CYP3A4 CYP3A5

7.69e-05151293CID000104757
Drug4-hydroxymephenytoin

CYP2A6 CYP3A4 CYP3A5

7.69e-05151293CID000119507
Drugthioridazine

CYP2A6 DRD1 CYP3A4 CYP3A5 CHRM3

8.70e-05791295CID000005452
DrugSuccimer

AMPD3 GPBP1 ATRX TRIM4 ORC3 POLA1 E2F7 SMC2 CBLB KIF20B PIEZO2 PIK3CA ZNF644 ITSN2 NFAT5 HECTD1 MGAT5B RAD54L SENP7

9.25e-05126412919ctd:D004113
Drug11,12,15-trihydroxyeicosatrienoic acid

CYP2A6 CYP2A7 CYP3A4 CYP3A5

9.32e-05421294CID006439610
Drugethyl iodoacetate

CYP2A6 CYP3A4 CYP3A5 HPSE

9.32e-05421294CID000012183
DrugNSC-141284

CYP2A6 CYP3A4 CYP3A5

9.43e-05161293CID000053981
Drugfullerene

CYP3A4 CYP3A5 SMC3

9.43e-05161293CID000123591
Drug4-nitropyrene

CYP2A6 CYP3A4 CYP3A5

9.43e-05161293CID000062134
DrugHCFC-141b

CYP2A6 CYP3A4 CYP3A5

9.43e-05161293CID000015586
DrugFluphenazine

CYP2A6 DRD1 CYP3A4

9.43e-05161293ctd:D005476
Drug6-hydroxychlorzoxazone

CYP2A6 CYP3A4 CYP3A5

9.43e-05161293CID000002734
Drugdesmethylazelastine

CYP2A6 CYP3A4 CYP3A5

9.43e-05161293CID000162558
Drug1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane

CYP2A6 CYP3A4 CYP3A5

9.43e-05161293ctd:C495657
Drugerythralosamine

CYP3A4 CYP3A5

9.52e-0531292CID000352196
Drug3-methoxymorphinan

CYP3A4 CYP3A5

9.52e-0531292ctd:C028657
Drugdechloroethylcyclophosphamide

CYP3A4 CYP3A5

9.52e-0531292ctd:C064445
Diseaseacute respiratory distress syndrome

FLT1 CHRM3 SMC3

2.89e-0741243EFO_1000637
DiseaseIntestinal Obstruction

SLC26A9 SLC9A3

5.24e-0531242C0021843
DiseaseCYSTIC FIBROSIS MODIFIER 1

SLC26A9 SLC9A3

1.05e-0441242C1859047
Diseasecomplex cortical dysplasia with other brain malformations (is_implicated_in)

KIF26A CAMSAP1

1.05e-0441242DOID:0090131 (is_implicated_in)
Diseasetacrolimus measurement

CYP3A4 CYP3A5

1.05e-0441242EFO_0008458
Diseasenon-small cell lung carcinoma

CYP2A6 LAMA1 CPS1 PIEZO2

2.87e-04751244EFO_0003060
Diseaseresponse to selective serotonin reuptake inhibitor

CYP2A7 KIF26B SLC26A9 KYNU

4.03e-04821244EFO_0005658
DiseaseAbdominal Cryptorchidism

ATRX CHRM3

4.82e-0481242C1563730
DiseaseInguinal Cryptorchidism

ATRX CHRM3

4.82e-0481242C1563731
DiseaseBilateral Cryptorchidism

ATRX CHRM3

4.82e-0481242C0431663
DiseaseUnilateral Cryptorchidism

ATRX CHRM3

4.82e-0481242C0431664
DiseaseMalignant neoplasm of breast

FLT1 RARB CYP3A4 SPTAN1 TRMT11 HPSE PIK3CA WDCP ZNF644 SYNE2 ITSN2 UTP20 RAD54L

6.01e-04107412413C0006142
Diseasesensory perception of sound

CYP2A6 GRM8

6.19e-0491242GO_0007605
DiseaseX-21467 measurement

CPS1 SLCO1C1

6.19e-0491242EFO_0020007
DiseaseCryptorchidism

ATRX CHRM3

7.71e-04101242C0010417
DiseaseAdenoid Cystic Carcinoma

ATRX BCOR PIK3CA MARK2

8.53e-041001244C0010606
Diseaseendometrial carcinoma, endometriosis

ARHGAP42 RARB

9.40e-04111242EFO_0001065, EFO_1001512
Diseasesalicylate measurement

ATP8B4 RARB

9.40e-04111242EFO_0021161
Diseasesodium measurement

CYP2A6 RARB DCDC1 NFAT5

9.53e-041031244EFO_0009282
DiseaseOsteosarcoma

CYP3A4 RFC1 BCOR

1.03e-03471243C0029463
Diseasenicotine metabolite ratio

CYP2A6 CYP2A7

1.12e-03121242EFO_0007794
Diseaseparaxanthine measurement

CYP2A6 BMPR1B

1.12e-03121242EFO_0021178
Diseasestomach carcinoma (is_implicated_in)

BCOR CBLB

1.12e-03121242DOID:5517 (is_implicated_in)
DiseaseSchizophrenia

DRD1 CYP3A4 CYP3A5 NPSR1 LAMA1 GRM8 OXTR PIK3CA KCNQ2 MARK2 NOS1AP

1.27e-0388312411C0036341
DiseaseNeoplasm of lung

CYP2A6 PIK3CA

1.54e-03141242cv:C0024121
Diseasethalamus volume change measurement

KIF26B LRFN5

1.54e-03141242EFO_0021496
DiseaseLung cancer

CYP2A6 PIK3CA

1.54e-03141242cv:C0242379
DiseaseLUNG CANCER

CYP2A6 PIK3CA

1.54e-03141242211980
Diseaseclonal hematopoiesis mutation measurement

CBLB HPSE KCNIP4

1.62e-03551243EFO_0020949
DiseaseC-reactive protein measurement

CYP2A6 CYP2A7 AMPD3 RARB CYP3A4 ORC3 TRMT11 ATP8B2 ZNF644 KCNIP4 CTNNA1 NFAT5 SF3B2

1.72e-03120612413EFO_0004458
DiseaseMammary Carcinoma, Human

FLT1 RARB CYP3A4 TRMT11 HPSE PIK3CA ITSN2 RAD54L

1.73e-035251248C4704874
DiseaseMammary Neoplasms, Human

FLT1 RARB CYP3A4 TRMT11 HPSE PIK3CA ITSN2 RAD54L

1.73e-035251248C1257931
DiseaseMammary Neoplasms

FLT1 RARB CYP3A4 TRMT11 HPSE PIK3CA ITSN2 RAD54L

1.77e-035271248C1458155
DiseaseHepatitis C

CYP2A6 CYP3A4

1.77e-03151242C0019196
DiseaseBreast Carcinoma

FLT1 RARB CYP3A4 TRMT11 HPSE PIK3CA ITSN2 RAD54L

2.02e-035381248C0678222
Diseaseureidopropionic acid measurement

CPS1 OTOG

2.02e-03161242EFO_0010542
Diseasecerebellum white matter volume change measurement

SLC27A5 NOS1AP

2.02e-03161242EFO_0021498
Diseaseserum metabolite measurement

TRIM4 CYP3A4 CYP3A5 KIF26B CPS1 SLC22A24 SLC9A3 KMT5B SYNE2 KCNIP4 KYNU

2.17e-0394512411EFO_0005653
Diseasechronic obstructive pulmonary disease

CYP2A6 AMPD3 FLT1 ATP8B4 RARB VPS54 CHRM3 SPATA9 TSLP

2.55e-036881249EFO_0000341
Diseasesmoking cessation

CYP2A6 CYP2A7 KIF26A KCNQ2 NFAT5 NOS1AP

2.57e-033251246EFO_0004319
Diseasecigarettes per day measurement

CYP2A6 CYP2A7 RARB DCDC1 UBE3B KCNIP4 NFAT5

2.57e-034381247EFO_0006525
Diseasemetabolonic lactone sulfate measurement

CYP3A4 CYP3A5

2.86e-03191242EFO_0800659
Diseasecaffeine metabolite measurement

CYP2A6 CYP2A7

2.86e-03191242EFO_0007872
Diseasepulmonary non-tuberculous mycobacterial infection

FLT1 CHRM3

2.86e-03191242MONDO_0018469
Diseaseetiocholanolone glucuronide measurement

CYP3A4 SLC22A24

2.86e-03191242EFO_0800362
Diseasecitrulline measurement

KIF26B CPS1

3.17e-03201242EFO_0009777
Diseaseandrosterone glucuronide measurement

CYP3A4 SLC22A24

3.17e-03201242EFO_0800317
Diseasesmoking behavior

CYP2A6 CYP2A7 COL16A1 RARB CNTNAP4 KDM4A

3.25e-033411246EFO_0004318
DiseaseBREAST CANCER

PIK3CA RAD54L

3.49e-03211242114480
Diseasedepressive disorder (implicated_via_orthology)

DRD1 NOS1AP

3.83e-03221242DOID:1596 (implicated_via_orthology)
Diseaseintellectual disability (implicated_via_orthology)

ZNF280A ATRX ITSN2

3.92e-03751243DOID:1059 (implicated_via_orthology)
Diseasered blood cell density measurement

DCDC1 CPS1 RFC1 ATP8B2 KIF20B WWC2 PIK3CA KDM4A SENP7 PGBD2

4.07e-0388012410EFO_0007978
Diseasecolorectal cancer

ARHGAP42 AMPD3 ATP8B4 TRIM4 CHRM3 KCNIP4 CAMSAP1 SLC27A5

4.07e-036041248MONDO_0005575
Diseasegeneralized anxiety disorder

LRFN5 CTNNA1

4.18e-03231242EFO_1001892

Protein segments in the cluster

PeptideGeneStartEntry
IMLRTLKVTFQKESR

PTPN18

171

Q99952
KTKKKTAMNTRDSRL

ZNF280A

521

P59817
VELMKFVSKVRNLKR

FAM209A

121

Q5JX71
YISVKVMLKSIKTRL

CDRT15L2

226

A8MXV6
RKAMLTSKLSKEQTL

CCDC148

51

Q8NFR7
LMLREKKISRSSALK

CTNNBL1

341

Q8WYA6
IPMSLARRVKKDTKF

CYP2A6

366

P11509
INFLSKSVNRMKKSR

CYP3A5

246

P20815
RLSLMKTSAIKKIRN

COL16A1

56

Q07092
RTKLTTIEAKRIMSI

IQCD

41

Q96DY2
TRSQITKRKRMSLVK

CHRM3

471

P20309
KLSREMIKFSFRTTR

CNTNAP4

1036

Q9C0A0
AVSRRKVKMVEFLLK

ANKRD36

171

A6QL64
KTKFKRTSIDRLMNT

ATP8B4

261

Q8TF62
KMSFKRETKVLKTLS

DRD1

261

P21728
ISREISRMSTLKKQK

ADCY10

606

Q96PN6
RLTALRVKKTLAKMS

BMPR1B

481

O00238
LSDVLKKLKMSSRIF

BCOR

1666

Q6W2J9
SVKMTSFAERKLQRL

CAMSAP1

811

Q5T5Y3
TAKRKKSFKMIRSQS

AMPD3

71

Q01432
TKFKRTSIDRLMNTL

ATP8B2

281

P98198
KILMKITDLRSISAK

RARB

376

P10826
TMSIKKRAKVVERFN

RAD54L

546

Q92698
IMSNTKLLKALRVRK

ITSN2

1261

Q9NZM3
SRLDKQMRKFTDIRK

IWS1

786

Q96ST2
QMRKFTDIRKKSRSA

IWS1

791

Q96ST2
KMTRLDVTSNKLQKL

LRFN5

196

Q96NI6
FKSKKMLLRRQSLQT

ANKRD34B

491

A5PLL1
VLSIRMKKLTERTSV

DCDC1

281

M0R2J8
MKKLTERTSVRILFF

DCDC1

286

M0R2J8
FSLRNKELKVAMKRT

OR10H2

291

O60403
KELKVAMKRTFLSTL

OR10H2

296

O60403
TERSLKDSLTRKTKM

MAGEB4

101

O15481
KDSLTRKTKMLVQFL

MAGEB4

106

O15481
IMKRTRRTEATDKKT

MAP7

606

Q14244
RRKKKSRMTFFVTQL

NPSR1

76

Q6W5P4
RLTKLTRMRTDKKSE

GPBP1

286

Q86WP2
TRMRTDKKSEFLKAL

GPBP1

291

Q86WP2
SVLSMKSLKERLTKI

LONRF1

746

Q17RB8
TIQIASRVLRMKKKK

KIF26B

791

Q2KJY2
VKKNSKSRTLTRQSM

KMT5B

401

Q4FZB7
ESKASKRLTKRVQQM

LETM1

601

O95202
IDSLMKKSKRAIRLF

CBLB

111

Q13191
TNFLRKSVKRMKESR

CYP3A4

246

P08684
SGKESLIFMKKRTKR

MGAT5B

246

Q3V5L5
MRFLVSKRKFKESLR

KCNQ2

546

O43526
LRNKEVKAAMRKVVT

OR4M1

291

Q8NGD0
SSKFQKRKMLRLSQD

KIF20B

291

Q96Q89
QNSTKRSIKERLMKL

KCNIP4

26

Q6PIL6
NIQKKAMTVREFRKI

KDM4A

86

O75164
FIRAMQKLSLASKRK

KIF26A

306

Q9ULI4
RVMFRRAQFLIKTKS

KCNG1

476

Q9UIX4
SKRRSQLKQAVAKMV

PSMD12

91

O00232
ISKAKIRTVKMTFII

OXTR

266

P30559
KRKRSFKAVVTAATM

GRM8

851

O00222
KERKLTFDPMTRQIK

MED26

421

O95402
KKSTRARLVFRVNIM

NFAT5

406

O94916
LSNKLIMDIRRFIKK

POLA1

1326

P09884
TKVLMASVQGSKRRK

HPSE

416

Q9Y251
RKKTRSMLLSSEQLK

PIK3CA

226

P42336
KMITKKFKRQVRSGS

MGAT4D

186

A6NG13
SFRNKDVTRALKKML

OR2T10

291

Q8NGZ9
ILKEMNSVKLRSVKR

MTFR1

241

Q15390
TLTKLLKDRRKMQTV

BAGE3

86

Q86Y29
FRSRSKMKTENLKKR

ATRX

146

P46100
MTRILTAFKVVRTLK

CPS1

1

P31327
LEKTKQKVRTMARDL

HECTD1

826

Q9ULT8
AVTRAKKRLIMTKSL

FBH1

921

Q8NFZ0
KKRLIMTKSLENILT

FBH1

926

Q8NFZ0
FAKSRKTVTRKEEMK

BRME1

106

Q0VDD7
SRKDKSLRIMSQKFV

E2F7

281

Q96AV8
SAIDKMTKKTRDLRR

CTNNA1

366

P35221
KSRQDLLKSIVSRMK

GCFC2

601

P16383
IPMSLARRVKKDTKF

CYP2A7

366

P20853
RMSQIKRLLSEKKTC

CD4

431

P01730
LRKSKMTSNEISKRI

DNAH14

2676

Q0VDD8
IKEKKTSSRIRFMLQ

EIF4G1

966

Q04637
SSSLQKLFREVRIMK

MARK2

91

Q7KZI7
DLMRLKRTTAASNKK

DNAI4

631

Q5VTH9
VIALQRSFRSKRSKM

IQCB1

321

Q15051
ALRRQKKKDTLMTSK

CDH12

636

P55289
FKSKKKSQAMRIVRT

NOS1AP

146

O75052
TLTKLLKDRRKMQTV

BAGE2

86

Q86Y30
LTRLKSKRARVAQMK

DHX37

826

Q8IY37
LENFKTKMRSTVSVR

CNTN3

121

Q9P232
SSRKLEREKTFIKSM

FAM171B

716

Q6P995
MRDFATTLKNKFRSK

DRP2

666

Q13474
MKERRASQKLSSKSI

RND3

1

P61587
KKVTIRMTIRKNECR

OTOG

2841

Q6ZRI0
MKELRRSKKQTKFEV

ORC3

536

Q9UBD5
TIKSMQLLFKRVKSQ

MROH2A

1291

A6NES4
VKQILSKVMEARRSK

UTP20

1946

O75691
RKKSSSDLSEIRKML

SENP7

21

Q9BQF6
TSRRLITMEKVKKFE

TRMT11

406

Q7Z4G4
ERQVRELKTKISAMK

SMC3

271

Q9UQE7
SFIILLKKMAKNSRT

TMC3

241

Q7Z5M5
EKTPKKSRVRFSNIM

SLC35F5

186

Q8WV83
SMEKRVSKIKTILLS

SYNE2

3901

Q8WXH0
RSTMKKELDAVRIKT

SLC22A24

321

Q8N4F4
QQRRSLFMKTKTVSL

SLC26A9

581

Q7LBE3
KVRSDKSLKFTRMQK

DNTT

276

P04053
RSNKKMVASKRKELS

RFC1

176

P35251
MFKLKSCIRRKTDSI

ARHGAP42

321

A6NI28
KKLTRMLASTQKVNR

LAMA1

1631

P25391
TMRKRLESFKSTKLG

SLC9A3

656

P48764
SLRNKDIKRALKMSF

OR7A17

291

O14581
LLSRIIMKEKQSTKV

SLC35E1

151

Q96K37
ETRSRNEVLRVKKKM

MYH6

1606

P13533
QKTSKIRMAIALAKI

SPATA9

56

Q9BWV2
TTKMRTNLKRFLGVE

CMTM1

131

Q8IZ96
TKRREIKMNVVFKSK

C10orf120

236

Q5SQS8
DKVFTSVKLMSILRK

PGBD2

351

Q6P3X8
MITTLKKIRRFKVSQ

PSIP1

396

O75475
VITMQTRKSLELKKK

TRIM61

161

Q5EBN2
KKKLRRMNRFTVAEL

SF3B2

451

Q13435
TISRAKIRTVKMTFV

AVPR1B

271

P47901
TRLRVKKLKRELSQM

WWC2

171

Q6AWC2
EVTSTFKLMKTRLVR

SLC27A5

636

Q9Y2P5
FQKIKSMAASRRAKL

SPTAN1

1746

Q13813
ITKRERTMVSTRFQK

SLCO1C1

676

Q9NYB5
TKLKMFRRLASVASK

PIEZO2

196

Q9H5I5
TQAMKKRRKRKVTTN

TSLP

121

Q969D9
KKFTVTVTMRTLDLI

MRPL28

121

Q13084
LMKAAAKVVESKRTR

TERF1

256

P54274
AKKVAFDKRIMTRTV

SMC2

636

O95347
RKRKMDVSKITRYTE

ZNF644

291

Q9H582
TMKTLRLRKNTVKFS

TMEM87B

376

Q96K49
KNRVLLFRTMVTKEK

UBE3B

651

Q7Z3V4
KSSFLLKFIRKMTSR

TARBP1

466

Q13395
KIKSQRMRISTEFSK

TRIM4

191

Q9C037
LVTFKKAVTMTRKVT

WDCP

321

Q9H6R7
LTLFIRKMKRSSSEI

FLT1

776

P17948
SRKILRSMSRKVTTN

VTI1B

191

Q9UEU0
RKTSQAVKMLRDKIA

VPS54

246

Q9P1Q0
QATMKALRKKSVLLT

KYNU

351

Q16719